Cancer cells

Preci’s Cancer Cell Isolation service provides researchers with primary cancer cells sourced from a range of phenotypically diverse cancer patients. By isolating cells directly from human tumor samples, we preserve the unique characteristics of each cancer type, including specific mutations, growth patterns, and molecular markers, offering an in-depth representation of various cancer phenotypes. This diversity supports studies on genetic variability, treatment response, and tumor behavior across different cancer profiles.
Our cancer cell isolations span a wide array of tumor types, including but not limited to lung, breast, liver, and colorectal cancers. Each batch undergoes stringent quality control to maintain cell viability, authenticity, and consistency, allowing researchers to study disease-specific traits such as aggressive growth phenotypes, resistance mechanisms, and molecular markers. These cells are ideal for investigating personalized therapeutic approaches, drug resistance, and targeted treatment strategies in a context that mirrors real-world patient diversity.